Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Office of Health Affairs

Executive Summary

Office Director Peter Rheinstein will serve as senior VP-medical and clinical affairs at Baltimore, Md.-based Cell Works, after retiring from FDA Sept. 30. The health affairs office was dissolved and partially folded into CDER in June (1"The Pink Sheet" June 28, p. 23)

You may also be interested in...

HHS Human Subject Protection Team Will Include Former FDAer Nightingale

Former FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, will work on human subject protection issues as one of his responsibilities in a new position at HHS.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts